From the NIH: Appearance of interferon in viral infections may cause asthma while controlling virus
JAMA 240(12): 1232
1978
ISSN/ISBN: 0098-7484 PMID: 79662 Document Number: 137534
Document emailed within 1 workday
Related Documents
Mackay, M. 1985: Asthma and viral infections New Zealand Medical Journal 98(778): 352-353Réfabert, L.; Mahut, B.; de Blic, J.; Scheinmann, P. 1996: Acute viral respiratory infections and asthma La Revue du Praticien 46(17): 2077-2082
Gawlik, R.; Pitsch, T. 1999: Viral infections, allergy and bronchial asthma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 7(39): 127-130
Burkhardt, U.; Eggers, H.J. 1993: Viral infections--clinical pictures and laboratory diagnosis. Part 5: Human immunodeficiency virus (HIV 1, HIV 2) to measles virus Fortschritte der Medizin 111(35-36): 559-561
Brockmeyer, N.H.; Mertins, L.; Spatz, D.; Tillmann, I.; Goos, M. 1992: Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 530-533
Romano, A.; Sadan, Y. 1988: Ten years of experience with human fibroblast interferon in treatment of viral ophthalmic infections Metabolic Pediatric and Systemic Ophthalmology 11(1-2): 43-46
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Tagawa, M.; Omata, M.; Yokosuka, O.; Uchiumi, K.; Imazeki, F.; Okuda, K. 1985: Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen Gastroenterology 89(6): 1224-1229
Pillonel, J.; Saura, C.; Courouce, A.M. 1998: Dépistage des marqueurs d'une infection par le VIH et les virus des hépatites B et C chez les donneurs de sang en France et risque résiduel de transmission de ces virus par transfusion sanguine - Screening of viral markers for HIV, HBV and HCV infections in blood donors in france and residual risk of viral transmission by blood transfusion Euro Surveillance 3(7): 76-79
Raj, R.; Sreenivas, V.; Mehta, M.; Gupta, S. 2011: Health-related quality of life in Indian patients with three viral sexually transmitted infections: herpes simplex virus-2, genital human papilloma virus and HIV Sexually Transmitted Infections 87(3): 216-220
Jankowska, R. 1986: Effect of influenza virus type a and interferon on various pathogenetic factors in bronchial asthma Polski Tygodnik Lekarski 41(34): 1065-1067
Khan, A. 1979: The syndrome of asthma, recurrent viral infections and T-cell immunodeficiency: investigations and management Annals of Allergy 43(2): 69-72
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Mécs, I. 1973: The kinetics of formation and sensitivity to interferon of viral intermediates appearing in chick cells infected with Semliki Forest virus Acta Virologica 17(3): 177-188
Vilcek, J. 1984: Adverse effects of interferon in virus infections, autoimmune diseases and acquired immunodeficiency Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 30: 62-77
De Bree, G.J.; van Leeuwen, E.M.M.; ten Berge, R.J.M. 2007: Immunological defense to viral infections: focus on virus-specific T cells Nederlands Tijdschrift Voor Geneeskunde 151(44): 2440-2444
Vermeer, B.J.; Bouwes Bavinck, J.N. 1998: Relevance of photo-immunosuppression for viral infections (i.e. human papilloma virus) European Journal of Dermatology: Ejd 8(3): 205-206
Allison, A.C. 1970: Effects of antilymphocytic serum on bacterial and viral infections and virus oncogenesis Federation Proceedings 29(1): 167-168
Lykova, E.A.; Vorob'ev, A.A.; Bokovoĭ, A.G.; Pobedinskaia, I.N.; Gevondian, V.S.; Gevondian, N.M.; Mitrokhin, S.D.; Minaev, V.I.; Dzis, N.B.; Makkaveeva, L.F.; Kovalev, I.V.; Murashova, A.O.; Bondarenko, V.M. 2000: Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte Antibiotiki i Khimioterapiia 45(10): 22-27
Carrano, V.A.; Barthold, S.W.; Beck, D.S.; Smith, A.L. 1984: Alteration of viral respiratory infections of mice by prior infection with mouse hepatitis virus Laboratory Animal Science 34(6): 573-576